IRIS
TORNIAI, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.446
EU - Europa 473
AS - Asia 99
Totale 2.018
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.446
IT - Italia 105
UA - Ucraina 87
IE - Irlanda 77
SE - Svezia 75
DE - Germania 48
TR - Turchia 39
SG - Singapore 29
DK - Danimarca 25
FI - Finlandia 25
BE - Belgio 14
GB - Regno Unito 14
KR - Corea 14
IN - India 9
CN - Cina 7
FR - Francia 1
JP - Giappone 1
LT - Lituania 1
RU - Federazione Russa 1
Totale 2.018
Salva come PNG Salva come JPEG
Città #
Chandler 218
Fairfield 139
Ashburn 134
Jacksonville 131
Des Moines 113
Dublin 77
Wilmington 73
Woodbridge 58
New York 56
Seattle 54
Houston 51
Cambridge 49
Ann Arbor 37
Lawrence 31
Princeton 31
Turin 31
San Mateo 30
Boardman 16
Brussels 14
San Diego 14
Washington 14
Los Angeles 13
Helsinki 11
Centro 10
Falls Church 9
Pune 9
Norwalk 7
Kilburn 6
Beijing 5
London 3
Montegiorgio 3
Castelraimondo 2
Chengdu 2
Cupra Marittima 2
Hounslow 2
Porto 2
Ancona 1
Bevagna 1
Cernusco sul Naviglio 1
Chiswick 1
Foligno 1
Mondolfo 1
New Bedfont 1
Redwood City 1
San Severino Marche 1
Sano 1
Trecastelli 1
Totale 1.468
Salva come PNG Salva come JPEG
Nome #
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 82
Gender differences and outcome of melanoma patients 81
Electrolyte disorders in cancer patients: a systematic review 80
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 79
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 77
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 77
Hyponatremia in cancer patients: Time for a new approach 75
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 75
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 75
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 73
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 73
Benefits and limitations of a multidisciplinary approach in cancer patient management 71
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 70
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 70
Gender Differences and Outcomes in Melanoma Patients 70
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 68
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 68
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 66
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 64
Systemic treatment for lung carcinoids: from bench to bedside 64
High CTLA-4 expression correlates with poor prognosis in thymoma patients 64
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 64
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 63
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 62
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 59
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 57
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 57
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 55
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 51
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 49
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 38
Totale 2.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/2020142 0 0 14 2 16 0 15 0 18 13 18 46
2020/2021551 36 50 80 24 67 32 27 45 55 51 48 36
2021/2022246 16 36 14 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024312 51 6 31 22 48 107 7 25 1 14 0 0
Totale 2.077